<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25885838</article-id><article-id pub-id-type="pmc">4173534</article-id><article-id pub-id-type="publisher-id">AER-7-228</article-id><article-id pub-id-type="doi">10.4103/0259-1162.118970</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of magnesium sulfate on hemodynamic response to carbon dioxide pneumoperitoneum in patients undergoing laparoscopic cholecystectomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paul</surname><given-names>Suhrita</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Biswas</surname><given-names>Pabitra</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Dhurjoti Prosad</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Sengupta</surname><given-names>Janmejoy</given-names></name><xref ref-type="aff" rid="aff3">2</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Department of Pharmacology, Medical College, Kolkata, India</aff><aff id="aff2"><label>1</label>Department of Anaesthesiology, Calcutta National Medical College, Kolkata, India</aff><aff id="aff3"><label>2</label>Department of Anaesthesiology, KPC Medical College, Kolkata, India</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Janmejoy Sengupta, HIG-Q1. Niva Park, Phase-II, P.O. Brahmapur, Kolkata - 700 096, India. E-mail: <email xlink:href="janmejoys@yahoo.co.in">janmejoys@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>May-Aug</season><year>2013</year></pub-date><volume>7</volume><issue>2</issue><fpage>228</fpage><lpage>231</lpage><permissions><copyright-statement>Copyright: &#x000a9; Anesthesia: Essays and Researches</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction:</title><p>Carbon dioxide pneumoperitoneum (PP) for laparoscopic surgery increases arterial pressure, heart rate, and systemic vascular resistance. In this randomized, double blind, prospective clinical study; we investigated the efficacy of magnesium sulfate to prevent adverse hemodynamic response associated with PP in patients undergoing laparoscopic cholecystectomy.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Sixty patients, of either sex (18-65 years of age), undergoing elective laparoscopic cholecystectomy were randomly allocated in one of the two groups containing 30 patients each. Group M received magnesium sulfate 30 mg/kg intravenously as a bolus before PP. Group C received same volume of 0.9% saline.</p></sec><sec id="st3"><title>Results:</title><p>Mean arterial pressure and heart rate were significantly less throughout the period of pneumoperitoneum in patients of group M. Intravenous labetalol was required in 40% (12 out of 30) of the patients in group C to control intraoperative hypertension and it was clinically significant in comparison to group M.</p></sec><sec id="st4"><title>Conclusion:</title><p>Magnesium sulfate administered before PP attenuates adverse hemodynamic response and provides hemodynamic stability during PP created for laparoscopic surgery.</p></sec></abstract><kwd-group><kwd>Hemodynamic</kwd><kwd>laparoscopic surgery</kwd><kwd>magnesium sulfate</kwd><kwd>pneumoperitoneum</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Laparoscopic cholecystectomy was first performed by Phillipe Mouret in 1987[<xref rid="ref1" ref-type="bibr">1</xref>] Since then it became popular very quickly. For laparoscopic cholecystectomy, carbon dioxide is commonly used to create pneumoperitoneum (PP).[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] Both carbon dioxide and PP cause adverse cardiovascular effects.[<xref rid="ref4" ref-type="bibr">4</xref>] Adverse cardiovascular changes are characterized by abrupt elevation of arterial pressure, systemic vascular resistance, and decreased cardiac output.[<xref rid="ref5" ref-type="bibr">5</xref>] These vasopressor responses are mainly due to increased release of catecholamines, vasopressin, or both.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] Laparoscopic cholecystectomy is performed in reverse Trendelenburg position.[<xref rid="ref8" ref-type="bibr">8</xref>] Cardiac output is further decreased secondary to decreased venous return caused by the above said position.</p><p>Severe increases in arterial pressure and heart rate can be deleterious to the patients, especially for the patients with compromised cardiac function.[<xref rid="ref9" ref-type="bibr">9</xref>] Attenuation of circulatory response to PP is usually done by opioids[<xref rid="ref10" ref-type="bibr">10</xref>] vasodilators[<xref rid="ref11" ref-type="bibr">11</xref>] beta blocking agents,[<xref rid="ref12" ref-type="bibr">12</xref>] and alpha-2 adrenergic agonists.[<xref rid="ref13" ref-type="bibr">13</xref>]</p><p>Magnesium has the ability to block the release of catecholamines from both the adrenal gland and the adrenergic nerve terminals.[<xref rid="ref14" ref-type="bibr">14</xref>] Apart from that, magnesium can produce vasodilatation by acting directly on blood vessels[<xref rid="ref15" ref-type="bibr">15</xref>] and it also capable of attenuating vasopressin-stimulated vasoconstriction.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Intravenously administered magnesium sulfate is capable of attenuating the adverse hemodynamic response associated with endotracheal intubation.[<xref rid="ref17" ref-type="bibr">17</xref>] So we have hypothesized that intravenously administered magnesium sulfate would be efficacious to attenuate adverse hemodynamic response in patients undergoing elective laparoscopic cholecystectomy with carbon dioxide PP.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>The study protocol was approved by the Institutional Ethical Committee of Calcutta National Medical College, Kolkata and informed consent was taken from each of the patients. Sixty American Society of Anesthesiologists (ASA) grade I and II patients, aged 18-65 years, undergoing elective laparoscopic cholecystectomy were assigned (using a computer derived random number sequence) to one of the two groups (each containing 30 patients): Group M (magnesium sulfate group) and Group C (control group). Group size of 30 patients was determined by power analysis study. Patients with hypermagnesemia;- known allergy to magnesium sulfate, hypertension; morbid obesity; and severe hepatic, renal, endocrine, and cardiac dysfunction were excluded from the study.</p><p>All the patients received tab. diazepam 10 mg orally on the night before surgery. On arrival to operation theatre, routine monitoring (ECG, pulse oximetry, noninvasive blood pressure (NIBP) was started and baseline vital parameters like heart rate, mean arterial pressure (MAP), and arterial oxygen saturation (SpO<sub>2</sub>) were recorded. An intravenous line was started. Patients were induced with fentanyl 2 &#x003bc;g/kg and propofol 2 mg/kg. Endotracheal intubation was facilitated by muscle relaxant rocuronium 0.7 mg/kg. Group M patients received magnesium sulfate 30 mg/kg intravenously as a bolus and group C received same volume of 0.9% saline. The study medication was prepared in identical 20 ml syringe: 8 ml sterile water was added to 12 ml magnesium sulfate (6000 mg) for group M patients (1 ml = 300 mg). 0.9% saline was used for group C patients. Study medication was prepared by an anesthesiologist who was blinded to the computer generated randomization schedule. Patients received one of these above said solution as a bolus intravenously immediately before pneumoperitonium.</p><p>Anesthesia was maintained with 33% O<sub>2</sub> in N<sub>2</sub>O, 0.6% isoflurane and rocuronium. CO<sub>2</sub> was insufflated into the peritoneal cavity to create PP. Intra-abdominal pressure (IAP) was maintained to 12 mmHg throughout the laparoscopic procedure. All the patients were positioned in a head-up tilt for about 15&#x000b0;. The patients were mechanically ventilated to keep ETCO<sub>2</sub> between 35-40 mmHg.</p><p>In case of acute and severe hemodynamic fluctuations, the following medical interventions were taken: For bradycardia (heart rate &#x0003c; 60 beats/min), i.v. bolus dose of 0.6 mg inj. atropine; for hypotension (MAP &#x0003c; 60 mmHg) increased rate of infusion of i.v. fluid and/or i.v. bolus dose of inj. phenylephrine, and for hypertension (MAP &#x0003e; 110 mmHg) i.v. bolus dose of inj. labetalol.</p><p>At the end of the operation, ondansetron 4 mg was administered for prophylaxis against nausea and vomiting. Residual neuromuscular block was reversed by appropriate dose of neostigmine and glycopyrolate and tracheal extubation was performed. Heart rate and MAP were recorded at the following points of time: (1) Baseline, (2) before PP, (3) 15 minutes after PP, (4) 30 minutes after, PP (5) after release of PP, and (6) after extubation. Patients were observed for any adverse events like bradycardia, hypotension, and hypertension during postoperative period in postanesthesia care unit.</p><sec id="sec2-1"><title>Statistical analysis</title><p>The results obtained from the study are presented in the following section in a tabulated manner. The results are expressed in Mean &#x000b1; SD. Comparison between groups were performed with the Kruskal-Wallis one way ANOVA by Ranks or Fisher's exact test for small samples with a 5% risk. Mann-Whitney-Wilcoxon tests were performed when tests of normal distribution failed. <italic>P</italic> &#x0003c; 0.05 was considered to be statistically significant (Graph Pad In Stat version 3.05, Graph Pad Software, San Diego, CA).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The groups were comparable with respect to age, sex, body-weight, and duration of surgery [<xref ref-type="table" rid="T1">Table 1</xref>]. There was no significant difference in the preoperative MAP values between two groups [<xref ref-type="table" rid="T2">Table 2</xref>]. Before PP, there is also no significant difference in MAP values between the groups. MAP values in group M were significantly lower (<italic>P</italic> &#x0003c; 0.05) throughout the PP, after the release of PP, and after extubation compared to group C [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient's characteristics and duration of surgery (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-7-228-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Changes in mean arterial pressure (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-7-228-g002"/></table-wrap><p>There was no significant difference in the preoperative heart rate between the groups [<xref ref-type="table" rid="T3">Table 3</xref>]. Before PP, there is also no significant difference in heart rate between the groups. Heart rate in group M were significantly lower throughout the PP (<italic>P</italic> &#x0003c; 0.05), after release of PP and after extubation in comparison to group C [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Changes in heart rate (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-7-228-g003"/></table-wrap><p>No patient suffered from bradycardia in our study. Only one patient in group M suffered from hypotension. Hypertension occurred in 12 patients of group C whereas no patient of group M suffered from hypertension. The difference was statistically significant (<italic>P</italic> &#x0003c; 0.05) [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Distribution of patients according to adverse effects</p></caption><graphic xlink:href="AER-7-228-g004"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>In the study, we studied the effects of magnesium sulfate on hemodynamics in patients undergoing laparoscopic cholecystectomy.</p><p>During laparoscopic surgery, CO<sub>2</sub> is routinely used to create PP.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Elevated IAP induced by PP and CO<sub>2</sub> itself produce some adverse effects on the cardiovascular system [<xref ref-type="fig" rid="F1">Figure 1</xref>].[<xref rid="ref3" ref-type="bibr">3</xref>] Immediately after PP, plasma level of catecholamines and vasopressin is increased. Increased catecholamine level activates the renin-angiotensin aldosterone system (RAAS) leading to some characteristic hemodynamic alterations[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] which include decreased cardiac output, elevated arterial pressure, and increased systemic/pulmonary vascular resistance. Vasopressin also contributes to elevation of arterial pressure and systemic vascular resistance.[<xref rid="ref6" ref-type="bibr">6</xref>] Laparoscopic cholecystectomy is performed in reverse Trendelenburg position.[<xref rid="ref7" ref-type="bibr">7</xref>] This particular position causes diminished venous return which ultimately leads to further decrease in cardiac output.[<xref rid="ref8" ref-type="bibr">8</xref>] As already mentioned in introduction, various pharmacological agents have been used to attenuate these adverse hemodynamic effects of PP.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Schematic representation of hemodynamic changes due to elevated intra-abdominal pressure</p></caption><graphic xlink:href="AER-7-228-g005"/></fig><p>As stated earlier, magnesium is effective in blocking the release of catecholamines from both adrenergic nerve terminals and the adrenal gland.[<xref rid="ref14" ref-type="bibr">14</xref>] Besides, magnesium produces vasodilatation by acting directly on blood vessels.[<xref rid="ref15" ref-type="bibr">15</xref>] In addition to catecholamines, vasopressin is a major contributor to the hemodynamic changes induced by PP. Magnesium attenuates vasopressin stimulated vasoconstriction.[<xref rid="ref16" ref-type="bibr">16</xref>] In a study, James <italic>et al</italic>.[<xref rid="ref17" ref-type="bibr">17</xref>] observed that i.v. magnesium sulfate was able to attenuate the adverse hemodynamic response of endotracheal intubation. Because of the ability of magnesium sulfate to attenuate adverse hemodynamic response, we have administered 30 mg/kg magnesium sulfate as a bolus before PP and observed its effect on hemodynamic response to PP Telci and etal.[<xref rid="ref18" ref-type="bibr">18</xref>] used i.v. Magnesium sulfate in a dose of 30 mg/kg bolus before induction and 10 mg/kg/h continuous i.v. infusion in a study to observe the efficacy of magnesium sulfate to decrease anesthetic requirement.[<xref rid="ref18" ref-type="bibr">18</xref>] We did not administer any infusion of magnesium intraoperatively as to observe the efficacy of magnesium sulfate to decrease anesthetic requirement was not our goal. Still we observed that i.v. magnesium sulfate in a bolus dose of 30 mg/kg before PP was able to attenuate the adverse hemodynamic response.</p><p>Diamant <italic>et al</italic>.[<xref rid="ref19" ref-type="bibr">19</xref>] reported 35% decrease in cardiac output in dog with a raised IAP of 40 mmHg. Ishizaki <italic>et al</italic>.,[<xref rid="ref20" ref-type="bibr">20</xref>] tried to evaluate the safe IAP during laparoscopic surgery. They observed significant fall in cardiac output at 16 mmHg of IAP and hemodynamic alterations were much less at 12 mm Hg of IAP. So in our study, we kept IAP 12 mm Hg. In spite of maintaining normocapnia and keeping IAP 12 mm Hg, there was significant rise of MAP and heart rate in patients of group C. However in group M, hemodynamic responses to PP were effectively blunted and both MAP and heart rate remained at a significantly lower level compared to group C. Thus in the present study, pre-pneumoperitoneum i.v. magnesium sulfate attenuated adverse hemodynamic response.</p><p>Regarding the incidence of adverse effects, no patient of either group suffered from bradycardia in our study and only single patient in group M suffered from hypotension. Hypertension occurred in 12 patients of group C for which they had to be treated with inj. labetalol whereas no patient of group M suffered from hypertension. To conclude, magnesium sulfate attenuates the elevation of MAP and heart rate during PP and thereby provides perioperative hemodynamic stability during laparoscopic surgery. Therefore, magnesium sulfate may be recommended for attenuation of adverse hemodynamic response during laparoscopic surgery.</p></sec></body><back><ack><title>ACKNOWLEDGEMENT</title><p>I want to thank all the members who were directly or indirectly involved in this project, and for their constant support to carry out my research.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecchio</surname><given-names>R</given-names></name><name><surname>Macfayden</surname><given-names>BV</given-names></name><name><surname>Palazzo</surname><given-names>F</given-names></name></person-group><article-title>History of laparoscopic surgery</article-title><source>Panminerva Med</source><year>2000</year><volume>42</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11019611</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>G</given-names></name><name><surname>Mc Clelland</surname><given-names>RM</given-names></name><name><surname>Newton</surname><given-names>JR</given-names></name></person-group><article-title>Some effects of the peritoneal insufflation of carbon dioxide at laproscopy</article-title><source>Anaesthesia</source><year>1970</year><volume>25</volume><fpage>382</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">4246974</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blobner</surname><given-names>M</given-names></name><name><surname>Felber</surname><given-names>AR</given-names></name><name><surname>G&#x000f6;gler</surname><given-names>S</given-names></name><name><surname>Weigl</surname><given-names>EM</given-names></name><name><surname>Jelen</surname><given-names>ES</given-names></name></person-group><article-title>Carbon dioxide uptake from the pneumoperitoneum during laparoscopic cholecystectomy</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>A37</fpage><lpage>40</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>JD</given-names></name><name><surname>Trinkl</surname><given-names>JK</given-names></name></person-group><article-title>Haemodynamic and respiratory alterations with increased intra abdominal pressure</article-title><source>J Surg Res</source><year>1976</year><volume>20</volume><fpage>401</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">933497</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>RJ</given-names></name><name><surname>Thomas</surname><given-names>TA</given-names></name><name><surname>Wilkins</surname><given-names>DG</given-names></name></person-group><article-title>Cardiovascular changes during laparoscopy. Studies of stroke volume and cardiac output using impedance cardiography</article-title><source>Anaesthesia</source><year>1976</year><volume>31</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">130811</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myre</surname><given-names>K</given-names></name><name><surname>Rostrup</surname><given-names>M</given-names></name><name><surname>Buanes</surname><given-names>T</given-names></name><name><surname>Stokland</surname><given-names>O</given-names></name></person-group><article-title>Plasma catecholamines and haemodynamic changes during pneumoperitoneum</article-title><source>Acta Anaesthesiol Scand</source><year>1998</year><volume>42</volume><fpage>343</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9542563</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walder</surname><given-names>AD</given-names></name><name><surname>Aitkenhead</surname><given-names>AR</given-names></name></person-group><article-title>Role of vasopressin in the haemodynamic response to laparoscopic cholecystectomy</article-title><source>Br J Anaesth</source><year>1997</year><volume>78</volume><fpage>264</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9135302</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>S</given-names></name><name><surname>Vandar</surname><given-names>LD</given-names></name></person-group><article-title>Trendelenburg and his position! A critique of its uses nad effectiveness</article-title><source>Anesth Analg</source><year>1988</year><volume>67</volume><fpage>574</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">3288005</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>JG</given-names></name><name><surname>Scheeres</surname><given-names>D</given-names></name><name><surname>Dean</surname><given-names>R</given-names></name><name><surname>Bonnell</surname><given-names>BW</given-names></name></person-group><article-title>The adverse haemodynamic effects of laparoscopic cholecystectomy</article-title><source>Surg Endosc</source><year>1995</year><volume>9</volume><fpage>121</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7597577</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lentschener</surname><given-names>C</given-names></name><name><surname>Axler</surname><given-names>O</given-names></name><name><surname>Fernandez</surname><given-names>H</given-names></name><name><surname>Megarbane</surname><given-names>B</given-names></name><name><surname>Billard</surname><given-names>V</given-names></name><name><surname>Fouqueray</surname><given-names>B</given-names></name><etal/></person-group><article-title>Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>527</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">11308999</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joris</surname><given-names>JL</given-names></name><name><surname>Hamoir</surname><given-names>EE</given-names></name><name><surname>Hartstein</surname><given-names>GM</given-names></name><name><surname>Meurisse</surname><given-names>MR</given-names></name><name><surname>Hubert</surname><given-names>BM</given-names></name><name><surname>Charlier</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Haemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">9895059</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koivusalo</surname><given-names>AM</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name><name><surname>Tikkanen</surname><given-names>I</given-names></name><name><surname>Yli-Suomu</surname><given-names>T</given-names></name><name><surname>Ristkari</surname><given-names>S</given-names></name><name><surname>Laakso</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effects of esmolol on haemodynamic response to CO pneumoperitoneum for laparoscopic surgery</article-title><source>Acta Anaesthesiol Scand</source><year>1998</year><volume>42</volume><fpage>510</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9605365</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joris</surname><given-names>JL</given-names></name><name><surname>Chiche</surname><given-names>JD</given-names></name><name><surname>Canivet</surname><given-names>JL</given-names></name><name><surname>Jacquet</surname><given-names>NJ</given-names></name><name><surname>Legros</surname><given-names>JJ</given-names></name><name><surname>Lamy</surname><given-names>ML</given-names></name></person-group><article-title>Hemodynamic changes induced by laparoscopy and their endocrine correlates: Effects of clonidine</article-title><source>J Am Coll Cardiol</source><year>1998</year><volume>32</volume><fpage>1389</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">9809953</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lishajko</surname><given-names>F</given-names></name></person-group><article-title>Releasing effect of calcium and phosphate on catecholamines, ATP, and protein from chromaffin cell granules</article-title><source>Acta Physiol Scand</source><year>1970</year><volume>79</volume><fpage>575</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">4319536</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altura</surname><given-names>BM</given-names></name><name><surname>Altura</surname><given-names>BT</given-names></name></person-group><article-title>Magnesium and vascular tone and reactivity</article-title><source>Blood Vessels</source><year>1978</year><volume>15</volume><fpage>5</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">630136</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurant</surname><given-names>P</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Schiffrin</surname><given-names>EL</given-names></name></person-group><article-title>Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats</article-title><source>Can J Physiol Pharmacol</source><year>1997</year><volume>75</volume><fpage>293</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">9196855</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>MF</given-names></name><name><surname>Beer</surname><given-names>RE</given-names></name><name><surname>Esser</surname><given-names>JD</given-names></name></person-group><article-title>Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation</article-title><source>Anesth Analg</source><year>1989</year><volume>68</volume><fpage>772</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2735543</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telci</surname><given-names>L</given-names></name><name><surname>Esen</surname><given-names>F</given-names></name><name><surname>Ackora</surname><given-names>D</given-names></name><name><surname>Erden</surname><given-names>T</given-names></name><name><surname>Canbolat</surname><given-names>T</given-names></name><name><surname>Akpir</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of effects of magnesium sulfate in reducing intraoperative anesthetic requirements</article-title><source>Br J Anaesth</source><year>2002</year><volume>89</volume><fpage>594</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12393361</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamant</surname><given-names>M</given-names></name><name><surname>Benumof</surname><given-names>JL</given-names></name><name><surname>Saidman</surname><given-names>LJ</given-names></name></person-group><article-title>Haemodynamics of increased intra-abdominal pressure: Interaction with hypovolemia and halothane anesthesia</article-title><source>Anaesthesiology</source><year>1978</year><volume>48</volume><fpage>23</fpage><lpage>7</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizaki</surname><given-names>Y</given-names></name><name><surname>Bandai</surname><given-names>Y</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Ohtomo</surname><given-names>Y</given-names></name><name><surname>Idezuki</surname><given-names>Y</given-names></name></person-group><article-title>Safe intraabdominal pressure of carbon dioxide pneumoperitoneum during laparoscopic surgery</article-title><source>Surgery</source><year>1993</year><volume>114</volume><fpage>549</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">8367810</pub-id></element-citation></ref></ref-list></back></article>